Cogent Biosciences (COGT) operating margin

Operating margin · fiscal 2020
-1044.3%

Cogent Biosciences (COGT) had an operating margin of -1044.3% in fiscal 2020 (the year ended December 31, 2020). That is 901.3 percentage points lower than the -143.0% of fiscal 2019. Figures as of 17 Nov 2026, 20:52 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Operating margin, fiscal 2020
-1044.3%
Change on fiscal 2019
−901.3 pts
Highest on record
-143.0%fiscal 2019
Lowest on record
-1044.3%fiscal 2020
Fiscal years on record
42017–2020

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Cogent Biosciences operating margin, in more detail

Across the 4 fiscal years on record (2017–2020), the highest was -143.0% in fiscal 2019 and the lowest -1044.3% in fiscal 2020. The fiscal 2020 figure is no higher than in any of the 3 earlier fiscal years on record, whose median is -312.8%.

Net margin was -950.4% in fiscal 2020.

History · 4 fiscal years

Operating margin by fiscal year

  • Operating margin
  • Net margin

Cogent Biosciences operating margin, year by year

Cogent Biosciences (COGT) operating margin by fiscal year
Fiscal yearOperating marginChangeYear endedNet margin
2020-1044.3% 901.3 pts down-950.4%
2019-143.0% 226.9 pts up-141.5%
2018-369.9% 57.1 pts down-354.8%
2017-312.8%—-304.9%

Change is on the fiscal year before, in percentage points; a dash means that year is not on record. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Operating margin is operating income divided by revenue; gross margin does the same with gross profit, and net margin with net income.

How to read it

It shows how much of each unit of sales survives the cost of running the business — rising margins point to pricing power or scale, falling ones to pressure.

Operating margin at health care companies of similar size

Operating margin of Cogent Biosciences and comparable companies
CompanyOperating marginFiscal year
Teleflex TFX12.8%2025
Mirum Pharmaceuticals MIRM-4.2%2025
Grifols GRFS16.6%2025
Cogent Biosciences COGT-1044.3%2020
GRAIL GRAL-363.0%2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on COGT

Cogent Biosciences, figure by figure

Cogent Biosciences (COGT) overview: price, valuation and scorecardAll health care companies by market value

Cogent Biosciences operating margin: questions and answers

What is Cogent Biosciences's operating margin?

Cogent Biosciences (COGT) had an operating margin of -1044.3% in fiscal 2020 (the year ended December 31, 2020). That is 901.3 percentage points lower than the -143.0% of fiscal 2019.

Is Cogent Biosciences's operating margin high or low compared with its own history?

The fiscal 2020 figure is no higher than in any of the 3 earlier fiscal years on record, whose median is -312.8%.

What are the highest and lowest operating margin figures on record for Cogent Biosciences?

Across the 4 fiscal years on record (2017–2020), the highest was -143.0% in fiscal 2019 and the lowest -1044.3% in fiscal 2020.

What are Cogent Biosciences's gross and net margins?

Net margin was -950.4% in fiscal 2020.

How is Cogent Biosciences's operating margin calculated?

Operating margin is operating income divided by revenue; gross margin does the same with gross profit, and net margin with net income.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Cogent Biosciences (COGT) operating margin”, data as of 17 November 2026. https://funkfolio.com/stock/COGT/operating-margin

Underlying data: the company's filings with the SEC and Yahoo Finance.